Key facts
- Described as a Broad core institute member who works on the same floor as Minikel and Vallabh and who approached them in 2018 to propose a collaboration.
- Senior author of "In vivo base editing extends lifespan of a humanized mouse model of prion disease" (Nature Medicine, online 14 January 2025): 37 percent editing, 50 percent PrP reduction and 52 percent longer lifespan.
- His laboratory pioneered the base editing technique used; he called the result a milestone.
- The work was funded by the NIH, the Broad, Prion Alliance and HHMI.
- The base editing team is led by Vallabh, Minikel and Liu; chemical biologist Jessie Davis presented single-AAV progress at ASGCT 2026.
Timeline
- 2018Proposes the collaboration with the Vallabh/Minikel group.
- 2025Nature Medicine paper online.
- 2025Describes the result as a milestone.
- 2026Group presents base editing progress at ASGCT.
Institutions
Projects and trials
Research papers
Works with
This page covers public professional work only. To correct it or ask for it to be removed, write to hello@thegenerativebrain.org.
Last checked 16 October 2026
Sources for this page
- Broad Institute: gene editing extends lifespan in mouse model of prion disease
- In vivo base editing extends lifespan of a humanized mouse model of prion disease (Nature Medicine 2025)
- Harvard Gazette: team hits milestone toward prion disease treatment
- The Scientist: base editing silences prion protein (ASGCT 2026)